Topic Archives: BioTime (BTX)

This is the intro that was catching the attention of Gumshoe readers over the weekend, from an ad for Ray Blanco’s Breakthrough Technology Alert ($2,000/yr, no refunds): “THE WORLD’S FASTEST FORTUNE “Tiny company to hit $100 billion valuation faster than any other biotech in history… “Here’s how you can get FREE SHARES* — for potential […]

The latest pitch from Breakthrough Technology Alert, the high-priced tech “upgrade” newsletter from Agora Financial, is certainly over the top… this is how it opens: “Witness a Miracle Made Real “A shocking, exclusive video below reveals the most urgent market story of your lifetime. “Your fast action today could kick off lasting generations of wealth […]

Today we’ve got a two-fer — two different big publishers are teasing different “liquid biopsy” stocks, and I’m no expert on the technology or the prospects for this diagnostic “trend” that we’ve been hearing more about… so I’ll just sift the clues, identify the companies, and let you chatter about their merits amongst yourselves. The […]

Today we’ve got an interesting tease that a few readers sent in — it’s from the White Cap Report folks, who generally look for potentially high-octane growth stocks, and it’s about some kind of biotech stock. Here’s how they get our blood flowing this fine morning: “California Biotech Cleared to Bypass FDA – Next Month […]

This particular teaser ad is the most popular and intriguing one that has come across in several months, if the number of forwarded copies and questions I’ve received is a reliable indicator. Though many ads now promise protection from calamity, and systems that can provide income or steady the waves for your portfolio, it appears […]

Comments

  • Just found this in Yahoo Finance on distribution of shares between AGE and BTX. BioTime to receive $43 million from Juv...

  • Thank you so much for this information....

  • BTX Biotime, will spin off AgeX. However, one has to stretch a bit to think that the 2 parts will suddenly become vastl...

  • $BTX “BioTime plans to submit the Renevia application for CE Marking later this quarter with an expected approval i...

  • $BTX LONG 01-Feb-2018:08:19:00, BioTime, Inc. - Renevia Data from the Successful Pivotal Trial to Be Presented at ...

  • $BTX np and not planning to enter I have been following BTX off and on for a few years and need to preface this post ...

  • $BTX - February 3rd , 18 - Renevia(R) Data From the Successful Pivotal Trial to Be Presented at the IMCAS Conference 7:...

  • $BTX Bought Biotime in AH trading. Liked what I saw in all three strategic directions. Thanks Doc for your comprehen...

  • $aBTX np, Biotime is a long-time Patrick Cox favorite. Today's column: http://www.mauldineconomics.com/tech/tech-digest/...

  • $BTX also uses pluripotent cells, which can be turned into anything, such as retinal pigm. epithelial cell to tx dry AMD...

  • Biotime....could this one be getting ready for primetime? $BTX It owns OncoCyte and Asterias, positions each valued a...

  • $BTX np Dr. James Van Allen lectured for decades about the Van Allen radiation belt, the zone of energetic charged parti...

  • You sound like a $BTX long. Is there a reason you did not declare that? Or just dropping by to pump and dump? I don't...

  • $BTX is an alternative to CWBR. just raised $25 million, same capitalization as CWBR, spins off several biotech companie...

  • $BTX np, $CWBR 2or 3xow - Marianne, Thank YOU for sharing your excellent, prescient book review on Juvenescence. I not...

  • I would say Marc Lichtenfeld offered the 300,000% as a long term (retire on) potential if it was applied to all genetic...

  • Jokin: and I hope you never take one (position in $OCX). This company barely has a toe in liquid biopsy and is using tha...

  • Also, John, I attended the $BTX 30-minute corporate presentation at Noblecon13.....I definitely wasn't moved by it. I se...

  • $BTX np According to Mark Humayan, MD, PhD at USC Roski Eye Institute, solutions of RPE cells injected into sub-retin...

  • Patrick Cox pumping Asterias Biotherapeutics (AST) again. http://www.mauldineconomics.com/tech/tech-digest/the-medical-...

  • $BTX np - Article Jan 24th on BioTuesday: BioTime leading advances in regenerative medicine http://www.biotuesdays.c...

  • HI EYEDOC, HOW DOES OPREGN $BTX DRY AMD INJECTION COMPARE TO WET AMD, I KNOW THEY DIFFRENT EYE DISEASES HOWEVER THEIR ...

  • $BTX np Doc, you are correct that this would help in cases that are not amenable to anti VEGF treatment. Still..........

  • $BTX np This post is in response to Doc's inquiry about the OpRegen program for AMD that is being trialed in Israel a...

  • BioTime $BTX presentation Regenerative medicine programs via Asterias subsidiary: video shown of quadriplegics having...

  • I am on premises at NobleCon13. A few minutes ago, I was able to secure a tentative interview with Mr. Caruso, the CEO o...

  • found Dr KSS comment on BioTime #BTX via spreadsheet http://www.stockgumshoe.com/2014/07/microblog-yellow-eyes-white-po...

  • Thanks, Travis for sleuthing the pitch to BioTime. While the time may not be ripe to invest in BTX, it is that time o...

  • $BTX BioTime no position "For the first time ever, neuroscientists have treated a total quadriplegic (a 21-year-old youn...

  • Doc, on the topic of liquid biopsies and the large competition in that area, are you familiar with OncoCyte $OCX? $OCX i...

  • Hi Doc, I don't know what to say about BTX. I don't know what I'm doing and probably never should have gotten in a posi...

  • Biotime (BRX) subsidiary ES Cell International deal with GE Healthcare back in December. Interesting that GE Healthcare ...

  • On the line of using technology, I have been looking at this company BioTime (BTX) which is a stem cell company with a ...

  • Doc, you forgot to comment on boring old $JNJ! :) Also, would you be so kind as to comment on current BioTime $BTX and ...

  • Re: BTX BioTime CEO Dr. Michael D. West to Discuss BioTime's Growth, Cell-Based Therapies and Diagnostics on Bloomberg...

  • $BTX ALAMEDA, Calif.--(BUSINESS WIRE)-- BioTime, Inc.(BTX) and its subsidiary OncoCyte Corporation today announced the ...

  • Asterias Bio up 35% on massive volume. No apparent news. BioTime (BTX) owns approx. 70% of this company. Long BTX. N...

  • Re: BTX -- 2/24/15 BioTime Announces First Patient Treated in Pivotal Clinical Trial of Renevia™ for HIV-Associated...

  • BTX -- 2/17/15 Dow Jones News Headlines • BioTime Says U.S. Patent Relating to Proprietary Method Of Manufacturing...

  • Here's some BioTime (BTX) news on new patents, plus an unrelated new Seeking Alpha article on the company for those who ...

  • Stock to watch today: BioTime (BTX). Eclipsed $4/share briefly this morning and already has higher than average volume ...

  • Happy New Year Dr. KSS. and fellow Gummies. Would you be willing to discuss the science, management and interest in h...

  • LOL good one, Doc. I wouldn't buy AST ... I think Biotime (BTX) is the better play, as it has many irons in the fir...

  • Hi Doc, Is it worth looking at AST ? Asterias Biotherapeutics, member of Biotime family companies, was selected as...

  • Opposeable- regarding BioTime and Asterias... BioTime owns about 71% of Asterias... So by today's market cap, that's abo...

  • Asterias Biotherapeutics making a nice move today. I think this was part of Biotime (BTX). I know there are some Biotime...

  • ALAMEDA, Calif.--(BUSINESS WIRE)--Nov. 4, 2014-- BioTime, Inc. (NYSE MKT:BTX) today reported that it has received author...

  • BioTime, Inc. has added a news release to its Investor Relations website. Title: BioTime's Subsidiary Cell Cure Neuros...

  • Cox is a lover of "cool" and of new stories, which is what newsletter subscribers really pay for -- that doesn't mean al...

  • He is a journalist who became a newsletter writer, and yes, his forte is science and medicine -- He spent years pumping ...

  • BIOTIME ANNUAL MEETING: Shareholder Letter https://materials.proxyvote.com/Approved/09066L/20140919/SHLTR_222588.PD...

  • Hey guys, I am in bluebird bio (BLUE) as well. Smart people are running this company and smart people are betting on the...

  • Hi Pockets, Yes, I agree the technicals are bullish. BTX is waking up lately and has developed a short term uptrend. ...

  • BioTime (BTX) subsidiary Asterias Bio (ASTY) announced that they gained approval to uplist onto the NYSE! BioTime owns ...

  • http://seekingalpha.com/article/2543805-biotime-is-right-on-time-files-ind-for-amd BioTime (NYSEMKT:BTX) recently ann...

  • I know most of the focus will be on DRTX today, and rightly so. I'm so pissed off I sold this one when my trailing stop...

  • BioTime (BTX) is not traded OTC. It is traded on the AMEX and no one should have any trouble trading it in any account....

  • A suggestion to Alan Harris regarding his comment in #183 above that "it's hugely expensive to trade OTC from UK." Ala...

  • Thanks Doc and Eliott for your input re stem cell plays. I'll look into Biotime. Also seems that Stem Cells Inc. (STEM...

  • Lol yes, I see the good doctor beat me to it: I think BioTime (BTX) is far and away the best and brightest in this space...

  • ScotsLad: I am not averse to gaming that space a little. But one main ground rule I suggest is NO stem cell plays for ca...

  • For those interested in BioTime, here is a link to the recent investor presentation (slides) http://investor.biotimeinc...

  • Eliott and Dr KSS; Re BioTime (BTX), If I am remembering correctly from a previous thread, Dr. KSS was at a conference a...

  • Hi Guys, I have mentioned BioTime (BTX) previously, but I would like to highlight recent price movement. The chart was...

  • BioTime (BTX) subsidiary, Asterias Biotherapeutics (ASTY) is blasting off today, up 21% on 2x average volume. Last I ch...

  • Some Asterias Bio news (Asterias trades as ASTY. It is a subsidiary of BioTime (BTX), which I own shares of): Dose Es...

  • Hi Kris: I think the main difference between Oncocyte and Biocept is that Oncocyte is going exclusively after circulatin...

  • Sorry it was Lawrence who posted (#221) the link to SA article about Biotime. Credit where credit due....

  • Logging in after a hiatus. Thanks Elliot for the info on Biotime. Mention is made in the article in SA that you brought ...

  • Also, BioTime subsidiary Asterias Bio is now traded over the counter as ASTYV. I cannot find the number of shares outst...

  • Found this in BioTime (BTX)'s 10-Q, which I am digging through this morning "On August 7, 2014 we were notified by the ...

  • BioTime news: Title: BioTime, Inc. Subsidiary OncoCyte Corporation Expands Clinical Development of Bladder Cancer Diag...

  • Hoping this is still the current thread- I was looking for comments on GERN through all the other threads and didn't...

  • BioTime (BTX) is rallying strongly today and looks like it might have formed a new "higher low". Could be a big deal if...

  • Eliott: Yes thank you I was aware of the company and got my wires crossed when I was trying to find a symbol that could ...

  • Eliott: Yes thank you I was aware of the company and got my wires crossed when I was trying to find a symbol that could ...

  • Tom ... Dr. KSS highlighted Biotie in this article, not BioTime. Biotie trades OTC as BIOZF. It does not trade on a ma...

  • Thanks Eliott: My bad. So is there only OTC on Biotime or is this the symbol for international trade? NASDAQ OMX Helsin...

  • This is incorrect. BTX is BioTime, not Biotie....

  • Timmuggs: Asterias is a unit of Biotime (BTX). I would not suggest investing in StemCells here until it shows it has ...

  • Hey Tim, I've never heard of StemCells, but I do know Asterias and I did hear about them getting this money. Asterias ...

  • Elliot: the insider buying is a good point about Biotime, and yes if you are in I would stay in. I think it is an opport...

  • Elliot: we had talked some previously about BioTime. The current BioTime incarnation has nothing in common with its prio...

  • Yes, yes, frank of course this is understandable. I'm beginning to think I will take a small position if not simply to ...

  • Getting interesting here ... $5,000,000 of venture seed funding given to LifeMap Sciences (subsidiary of BioTime (BTX)) ...

  • The BioTime (BTX) shareholder letter is quite an interesting read if anyone is interested. This CEO is quite a good wri...

  • So it turned out to be a 12 hour work day for me, so I'm not sure if I'll get around to posting about BioTime (BTX) toni...

  • on BTX I think it’s safe to say that no one has noticed a quiet press release that came out of BioTime (NYSE: BTX...

  • On BTX I think it’s safe to say that no one has noticed a quiet press release that came out of BioTime (NYSE: BTX...

  • sorry, that CEO I mentioned is the CEO of Biotime subsidiary Asterias Biotherapeutics. He is a former Senior Executive ...

  • I think it has changed up quite a lot since then Elliott. I see that I have kind of incongruent recall about whether I l...

  • Elliott; I am not in Biotime now. It's one of those potentially really appealing companies I just haven't had time to pa...

  • Hey Doc, are you still in BioTime (BTX)? I did some backreading on this one and saw a post of yours on a Travis article...

  • BTX BioTime Inc taking off today, up 12%, anyone know why? Thanks...

  • To be clear from BBERG, its the Lp below (and current largest holder): Broadwood Partners Lp, Director,1, Buys 2,000,00...

  • Frenchy: Yes, I definitely think we should be following Biotime. I'd not write this company off at all. I need to refres...

  • A Biotime (BTX) insider bought 2 million shares today....

  • I feel like Ariadne trying to sort out the thread to save her lover--who then dumped her. A few comments on this wild a...

  • Greenfire: from what I have seen and read about ATHX, I think your opinion is quite reasonable. They had nice data at re...

  • We use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.

    More Info